Actomyosin Activity and Piezo1 Activity Synergistically Drive Urinary System Fibroblast Activation.


Journal

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
ISSN: 2198-3844
Titre abrégé: Adv Sci (Weinh)
Pays: Germany
ID NLM: 101664569

Informations de publication

Date de publication:
11 2023
Historique:
revised: 11 08 2023
received: 24 05 2023
medline: 27 11 2023
pubmed: 23 10 2023
entrez: 23 10 2023
Statut: ppublish

Résumé

Mechanical cues play a crucial role in activating myofibroblasts from quiescent fibroblasts during fibrosis, and the stiffness of the extracellular matrix is of significant importance in this process. While intracellular force mediated by myosin II and calcium influx regulated by Piezo1 are the primary mechanisms by which cells sense and respond to mechanical forces, their intercellular mechanical interaction remains to be elucidated. Here, hydrogels with tunable substrate are used to systematically investigate the crosstalk of myosin II and Piezo1 in fibroblast to myofibroblast transition (FMT). The findings reveal that the two distinct signaling pathways are integrated to convert mechanical stiffness signals into biochemical signals during bladder-specific FMT. Moreover, it is demonstrated that the crosstalk between myosin II and Piezo1 sensing mechanisms synergistically establishes a sustained feed-forward loop that contributes to chromatin remodeling, induces the expression of downstream target genes, and ultimately exacerbates FMT, in which the intracellular force activates Piezo1 by PI3K/PIP3 pathway-mediated membrane tension and the Piezo1-regulated calcium influx enhances intracellular force by the classical FAK/RhoA/ROCK pathway. Finally, the multifunctional Piezo1 in the complex feedback circuit of FMT drives to further identify that targeting Piezo1 as a therapeutic option for ameliorating bladder fibrosis and dysfunction.

Identifiants

pubmed: 37867255
doi: 10.1002/advs.202303369
pmc: PMC10667826
doi:

Substances chimiques

Actomyosin 9013-26-7
Calcium SY7Q814VUP
Myosin Type II EC 3.6.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2303369

Subventions

Organisme : National Natural Science Foundation of China
ID : 8227031992
Organisme : Natural Science Foundation of Sichuan Province
ID : 2022NSFSC1433

Informations de copyright

© 2023 The Authors. Advanced Science published by Wiley-VCH GmbH.

Références

BMC Biol. 2011 Nov 30;9:82
pubmed: 22126462
Front Pharmacol. 2021 May 31;12:698275
pubmed: 34135765
Am J Physiol Cell Physiol. 2002 Jul;283(1):C223-34
pubmed: 12055091
Cell Prolif. 2018 Jun;51(3):e12442
pubmed: 29424004
J Biol Chem. 2014 Apr 4;289(14):9833-43
pubmed: 24500715
ACS Nano. 2019 Jan 22;13(1):203-214
pubmed: 30500159
Urology. 2002 Jun;59(6):877-83
pubmed: 12031373
Biomaterials. 2021 Jan;268:120543
pubmed: 33260094
J Biol Chem. 2016 Mar 18;291(12):6083-95
pubmed: 26763235
Int J Urol. 1996 Nov;3(6):441-7
pubmed: 9170570
J Biol Chem. 2014 Nov 14;289(46):31673-31681
pubmed: 25305018
Physiology (Bethesda). 2010 Feb;25(1):50-6
pubmed: 20134028
J Pediatr Urol. 2017 Dec;13(6):574-580
pubmed: 29037864
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10832-10838
pubmed: 32358190
J Cell Mol Med. 2020 May;24(10):5615-5628
pubmed: 32243691
Front Physiol. 2020 Feb 14;11:89
pubmed: 32116794
Neurourol Urodyn. 2020 Nov;39(8):2128-2138
pubmed: 32949194
Nature. 2020 Nov;587(7835):567-576
pubmed: 33239794
EMBO Rep. 2011 Mar;12(3):259-66
pubmed: 21311561
Dev Dyn. 2011 Sep;240(9):2069-83
pubmed: 22016182
Int Immunopharmacol. 2021 Oct;99:107947
pubmed: 34311189
N Engl J Med. 2015 Mar 19;372(12):1138-49
pubmed: 25785971
Cell Mol Bioeng. 2017 Jul 18;10(5):405-415
pubmed: 31719870
Am J Pathol. 2021 Jan;191(1):18-25
pubmed: 33031756
Neurourol Urodyn. 2018 Jun;37(S4):S7-S12
pubmed: 30133788
Elife. 2016 Nov 30;5:
pubmed: 27901466
MedComm (2020). 2022 Sep 15;3(4):e169
pubmed: 36176734
Ageing Res Rev. 2020 Nov;63:101150
pubmed: 32846223
Sci Rep. 2016 Jan 14;6:19276
pubmed: 26763945
Prog Biophys Mol Biol. 2017 Nov;130(Pt B):170-191
pubmed: 28647645
J Biol Chem. 2014 Jun 6;289(23):16565-75
pubmed: 24759099
Am J Physiol Renal Physiol. 2016 Oct 1;311(4):F817-F821
pubmed: 27440781
Sci Transl Med. 2013 Jan 9;5(167):167sr1
pubmed: 23303606
Adv Sci (Weinh). 2023 Nov;10(33):e2303369
pubmed: 37867255
Nat Commun. 2021 May 31;12(1):3256
pubmed: 34059671
Biol Rev Camb Philos Soc. 2022 Apr;97(2):604-614
pubmed: 34781417
Nature. 2019 Sep;573(7772):69-74
pubmed: 31435009
Science. 2013 Aug 30;341(6149):1240104
pubmed: 23990565
Dev Cell. 2021 Mar 22;56(6):826-841.e4
pubmed: 33705692
Acta Biomater. 2019 Apr 15;89:47-59
pubmed: 30826478
JCI Insight. 2022 Apr 8;7(7):
pubmed: 35230979
Cell Microbiol. 2020 May;22(5):e13196
pubmed: 32083802
Commun Biol. 2019 Aug 7;2:298
pubmed: 31396578

Auteurs

Guo Chen (G)

Department of Urology, Institute of Urology (Laboratory of Reconstructive Urology), West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, P. R. China.
Department of Urology and Pelvic surgery, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, 610041, P. R. China.

Xiaoshuai Gao (X)

Department of Urology, Institute of Urology (Laboratory of Reconstructive Urology), West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, P. R. China.

Jiawei Chen (J)

Department of Urology, Institute of Urology (Laboratory of Reconstructive Urology), West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, P. R. China.

Liao Peng (L)

Department of Urology, Institute of Urology (Laboratory of Reconstructive Urology), West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, P. R. China.

Shuang Chen (S)

Department of Urology, Institute of Urology (Laboratory of Reconstructive Urology), West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, P. R. China.

Cai Tang (C)

Department of Urology, Institute of Urology (Laboratory of Reconstructive Urology), West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, P. R. China.

Yi Dai (Y)

Department of Urology and Pelvic surgery, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, 610041, P. R. China.

Qiang Wei (Q)

College of Polymer Science and Engineering, State Key Laboratory of Polymer Materials and Engineering, Sichuan University, Chengdu, Sichuan, 610065, P. R. China.

Deyi Luo (D)

Department of Urology, Institute of Urology (Laboratory of Reconstructive Urology), West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, P. R. China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH